Literature DB >> 6852442

Liquid crystal formation in ursodeoxycholate-rich human gallbladder bile.

H Igimi, S Asakawa, D Watanabe, H Shimura.   

Abstract

We studied liquid crystal formation in bile samples obtained from the patients with radiolucent gallstones who had been administered either ursodeoxycholic acid (UDCA) at a dose of 600 mg/day or chenodeoxycholic acid (CDCA) at 400 mg/day for one week preoperatively. The UDCA/total bile acids ratio was found to range from 50 to 60% and the CDCA/total bile acids ratio ranged from 70 to 80%. Cholesterol molar percent was 5 in UDCA-rich bile and 6 in CDCA-rich bile. Phospholipid molar percentage was about the same in both groups. Liquid crystal formation was confirmed only in the UDCA-rich bile samples but not in the CDCA-rich bile samples. This result suggests that cholesterol in the UDCA-rich bile samples is not solubilized by the bile salt and phospholipid mixed micelles but also consumed to form liquid crystals.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6852442     DOI: 10.1007/bf02774682

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  13 in total

1.  [Dissolution of cholesterol gallstones by long-term administration of ursodeoxycholic acid].

Authors:  I Makino; K Shinozaki; K Yoshino; S Nakagawa
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1975-06

2.  Ursodeoxycholate: a common bile acid in gallbladder bile of Japanese subjects.

Authors:  H Igimi
Journal:  Life Sci       Date:  1976-05-01       Impact factor: 5.037

3.  Quantitative determination of bile acids and their conjugates using thin-layer chromatography and a purified 3alpha-hydroxysteroid dehydrogenase.

Authors:  O Fausa; B A Skålhegg
Journal:  Scand J Gastroenterol       Date:  1974       Impact factor: 2.423

4.  Cholesterol gallstone dissolution in bile: dissolution kinetics of crystalline (anhydrate and monohydrate) cholesterol with chenodeoxycholate, ursodeoxycholate, and their glycine and taurine conjugates.

Authors:  H Igimi; M C Carey
Journal:  J Lipid Res       Date:  1981-02       Impact factor: 5.922

5.  [Treatment of gallstone with ursodeoxycholic acid--lipid and bile acid composition in bile (author's transl)].

Authors:  K Tanikawa; T Maeyama; H Abe; H Anno; M Okumura; Y Chuman; T Koji; S Nakagawa; Y Nakamura; H Iino; S Yamasaki; T Hisatsugu
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1978-08

6.  Mesophase formation during cholesterol dissolution in ursodeoxycholate-lecithin solutions: new mechanism for gallstone dissolution in humans.

Authors:  O I Corrigan; C C Su; W I Higuchi; A F Hofmann
Journal:  J Pharm Sci       Date:  1980-07       Impact factor: 3.534

7.  Hepatic cholesterol metabolism in patients with gallstones.

Authors:  G Salen; G Nicolau; S Shefer; E H Mosbach
Journal:  Gastroenterology       Date:  1975-09       Impact factor: 22.682

8.  Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. A multicenter double-blind trial. Tokyo Cooperative Gallstone Study Group.

Authors: 
Journal:  Gastroenterology       Date:  1980-03       Impact factor: 22.682

9.  pH-Solubility relations of chenodeoxycholic and ursodeoxycholic acids: physical-chemical basis for dissimilar solution and membrane phenomena.

Authors:  H Igimi; M C Carey
Journal:  J Lipid Res       Date:  1980-01       Impact factor: 5.922

10.  Enzymatic measurement of choline-containing phospholipids in bile.

Authors:  D Gurantz; M F Laker; A F Hofmann
Journal:  J Lipid Res       Date:  1981-02       Impact factor: 5.922

View more
  1 in total

1.  Hydrophilic bile acids: prevention and dissolution experiments in two animal models of cholesterol cholelithiasis.

Authors:  B I Cohen; T Mikami; N Ayyad; A Ohshima; R Infante; E H Mosbach
Journal:  Lipids       Date:  1995-09       Impact factor: 1.880

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.